LC-106
- Generic Name
- LC-106
Vaginal LIve Biotherapeutic RANdomized Trial
Early Phase 1
Completed
- Conditions
- Bacterial Vaginosis
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06135974
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇿🇦CAPRISA - Vulindlela, Msunduzi Municipality, KwaZulu Natal, South Africa
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath